Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Urokinase Therapy for Treatment of Angiopathic or Angioneuropathic Diabetic Foot Syndrome

NCT00537498 is registered in ClinicalTrials.gov with medac GmbH as lead sponsor.

NCT NCT00537498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Urokinase Therapy for Treatment of Angiopathic or Angioneuropathic Diabetic Foot Syndrome
Lead sponsor
medac GmbH
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2002
Completion date
December 31, 2006
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive disease, diabetic foot, ischemia